PTENP1 is reduced in cancer tissues compared to normal tissues, and lower PTENP1 levels predict worse overall survival, raising the possibility of PTENP1 as a novel diagnostic biomarker and treatment for glioma [95]. This evidence concerns the gene PTENP1 and central nervous system cancer.